Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Deferred Tax Assets / Liabilities ₹6.31 Cr₹4.98 Cr₹4.42 Cr₹4.58 Cr₹7.16 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹6.31 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹6.31 Cr
Mar2024₹4.98 Cr
Mar2023₹4.42 Cr
Mar2022₹4.58 Cr
Mar2017₹7.16 Cr

How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹6.31 Cr
26.80
Mar2024 ₹4.98 Cr
12.55
Mar2023 ₹4.42 Cr
-3.34
Mar2022 ₹4.58 Cr
-36.07
Mar2017 ₹7.16 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,396.8 Cr -3.9% -7.5% -31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,753.0 Cr -0.2% 6.1% 0.3% Stock Analytics
DIVIS LABORATORIES ₹167,998.0 Cr -1.4% -4.9% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,186.0 Cr 0.8% 5% 12.9% Stock Analytics
CIPLA ₹120,960.0 Cr -1.3% -0.5% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,759.0 Cr -0.7% 5.1% 4.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.9%

-7.5%

-31.4%

SENSEX

-0.6%

2.2%

5.3%


You may also like the below Video Courses